Abstract
In a clinical pilot study involving patients undergoing neoadjuvant chemotherapy, we explored evidence that diffuse optical tomography can be used to monitor tumor progression and predict treatment response.
© 2018 The Author(s)
PDF ArticleMore Like This
Jacqueline Gunther, Emerson Lim, Hyun Keol Kim, Mirella Altoe, Molly Flexman, Susan Refice, Mindy Brown, Kevin Kalinsky, Dawn Hershman, and Andreas H. Hielscher
JM4A.2 Cancer Imaging and Therapy (Cancer) 2016
Jacqueline Gunther, Emerson Lim, Hyun Keol Kim, Molly Flexman, Susan Refice, Mindy Brown, Kevin Kalinsky, Dawn Hershman, and Andreas H. Hielscher
BW4B.4 Biomedical Optics (BIOMED) 2014
Jacqueline E. Gunther, Emerson Lim, Hyun Keol Kim, Molly Flexman, Susan Refice, Mindy Brown, Kevin Kalinsky, Dawn Hershman, and Andreas H. Hielscher
87990P European Conference on Biomedical Optics (ECBO) 2013